Document is current
Any future updates will be listed below
-
Authors
Feto, Naser Aliye
Asuzu, Peace
Wan, Jim
Stentz, Frankie
Dagogo-Jack, Sam
Mandal, Nawajes
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK128129, DK067269, DK 48411)
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 16 April 2025
First Online: 5 May 2025
Declarations
:
: The authors report no conflicts of interest regarding the content of the manuscript.
: The CASPID study was approved by the Institutional Review Board (IRB) of the University of Tennessee Health Science Center (UTHSC) (IRB Approval #21–07936-FB) and conducted at the UTHSC General Clinical Research Center (GCRC). All participants gave written informed consent before taking part in the study.
